VC fund profile · evidence-aware directory data
Third Rock Ventures stages, portfolio and investment profile
Boston-based life sciences firm that co-founds and builds biotechnology companies alongside scientists, advancing breakthrough therapeutics from company creation through clinical development.
Keep track of Third Rock Ventures
Save this profile to your VCT watchlist for a quick return.
Stage-based planning range
$1M–$10M
This is a planning range inferred from stage coverage, not a firm-disclosed check size.
Methodology: Stage bucket inferred from the rounds a fund leads or invests in.
No firm-specific check-size disclosure is recorded.
Investment stages
Leads: Seed, Series A
Participates: Seed, Series A
Sector focus
biotech-life-sciences
Geography
Boston, MA
Founded 2007
Fund size / AUM
Not recorded
A separate fund-size evidence record is not yet available.
Portfolio in our directory
3
Linked startup profiles
Latest fund vehicle
Not recorded
Vehicle name, size, and vintage are not yet structured.
Recent tracked investment
Not recorded
No dated round explicitly links this fund.
Rounds they lead
Rounds they invest
Last verified: Not recorded. Check-size evidence is labeled by basis so planning estimates are not presented as firm disclosures.
Portfolio companies we track
Startups in our directory that list Third Rock Ventures as an investor (3 total).
- BioAge Labs Clinical-stage biotech targeting metabolic disease and aging biology (public: BIOA).
- Insitro ML-driven drug discovery platform applying large-scale biology data to identify novel therapeutics.
- Maze Therapeutics Clinical-stage biotech using human genetics to develop precision small-molecule medicines.
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.